Cargando…
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
Systemic sclerosis and systemic lupus erythematosus represent two distinct autoimmune diseases belonging to the group of connective tissue disorders. Despite the great progress in the basic science, this progress has not been translated to the development of novel therapeutic approaches that can rad...
Autores principales: | Kotyla, Przemysław, Gumkowska-Sroka, Olga, Wnuk, Bartosz, Kotyla, Kacper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413112/ https://www.ncbi.nlm.nih.gov/pubmed/36015084 http://dx.doi.org/10.3390/ph15080936 |
Ejemplares similares
-
Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023) -
Adhesion molecules: a way to understand lupus
por: Nowak, Karolina, et al.
Publicado: (2022) -
Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2023) -
Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2019) -
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?
por: Kotyla, Przemysław J., et al.
Publicado: (2021)